Ramon Garcia-Sanz, MD, PhD, clinician, department of Hematology, Hospital Universitario de Salamanca, discusses combination chemotherapy in patients with Hodgkin lymphoma.
Ramon Garcia-Sanz, MD, PhD
Advertisement
Articles by Ramon Garcia-Sanz, MD, PhD
Ramon Garcia-Sanz, MD, PhD, clinician, department of Hematology, Hospital Universitario de Salamanca, discusses the results of brentuximab vedotin (Adcetris) plus ESHAP followed by autologous stem cell transplant in patients with relapsed/refractory Hodgkin lymphoma.
Advertisement
Latest Updated Articles
Dr. Garcia-Sanz on Combination Chemotherapy for Relapsed/Refractory Hodgkin LymphomaPublished: August 15th 2018 | Updated:
Dr. Garcia-Sanz on Brentuximab Vedotin Plus ESHAP in Hodgkin LymphomaPublished: June 15th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5